147 related articles for article (PubMed ID: 6190596)
1. In vitro induction of human suppressor T cells by mycobacterial antigens. BCG activated OKT4+ cells mediate suppression of antigen induced T cell proliferation.
Mustafa AS; Godal T
Clin Exp Immunol; 1983 Apr; 52(1):29-37. PubMed ID: 6190596
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro.
Kaplan G; Gandhi RR; Weinstein DE; Levis WR; Patarroyo ME; Brennan PJ; Cohn ZA
J Immunol; 1987 May; 138(9):3028-34. PubMed ID: 3106496
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies.
Damle NK; Gupta S
Clin Exp Immunol; 1982 Jun; 48(3):581-8. PubMed ID: 6214339
[TBL] [Abstract][Full Text] [Related]
4. BCG induced CD4+ cytotoxic T cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro.
Mustafa AS; Godal T
Clin Exp Immunol; 1987 Aug; 69(2):255-62. PubMed ID: 2958195
[TBL] [Abstract][Full Text] [Related]
5. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients.
Bach MA; Wallach D; Flageul B; Cottenot F
Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031
[TBL] [Abstract][Full Text] [Related]
6. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients.
Brett SJ; Kingston AE; Colston MJ
Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217
[TBL] [Abstract][Full Text] [Related]
7. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
[TBL] [Abstract][Full Text] [Related]
8. BCG-induced suppressor T cells optimal conditions for in vitro induction and mode of action.
Mustafa AS; Godal T
Clin Exp Immunol; 1985 Dec; 62(3):474-81. PubMed ID: 2935339
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
11. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
12. Reduced suppressor cell response to Mycobacterium leprae in lepromatous leprosy.
Sasiain MD; de la Barrera S; Valdez R; Balina LM
Infect Immun; 1989 Mar; 57(3):951-6. PubMed ID: 2521841
[TBL] [Abstract][Full Text] [Related]
13. In vitro measurement of protective mycobacterial immunity: antigen-specific expansion of T cells capable of inhibiting intracellular growth of bacille Calmette-Guérin.
Worku S; Hoft DF
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S257-61. PubMed ID: 10875795
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and functional characterization of human suppressor T-cell clones: II. Activation by Mycobacterium leprae presented by HLA-DR molecules to alpha beta T-cell receptors.
Li SG; Elferink DG; de Vries RR
Hum Immunol; 1990 May; 28(1):11-26. PubMed ID: 1692823
[TBL] [Abstract][Full Text] [Related]
15. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
Mustafa AS
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
[TBL] [Abstract][Full Text] [Related]
16. Soluble antigen-primed inducer T cells activate antigen-specific suppressor T cells in the absence of antigen-pulsed accessory cells: phenotypic definition of suppressor-inducer and suppressor-effector cells.
Damle NK; Mohagheghpour N; Engleman EG
J Immunol; 1984 Feb; 132(2):644-50. PubMed ID: 6197471
[TBL] [Abstract][Full Text] [Related]
17. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
Palacios R
J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
[TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneities among concanavalin A-activated OKT4+ and OKT8+ cells by using autologous erythrocyte rosette technique.
Takada S; Ueda Y; Murakawa Y; Suzuki N; Sakane T
J Clin Invest; 1983 Dec; 72(6):2060-71. PubMed ID: 6227636
[TBL] [Abstract][Full Text] [Related]
19. Antigen-induced suppression in man: non-specific suppression mediated via OKT8+ cells.
Cohen MG; Munro AJ
Immunology; 1984 Aug; 52(4):589-98. PubMed ID: 6235178
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of T-cell unresponsiveness in leprosy.
Bach MA; Hoffenbach A; Lagrange PH; Wallach D; Cottenot F
Ann Immunol (Paris); 1983; 134D(1):75-84. PubMed ID: 6226239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
